Correlation Between JBG SMITH and Pharmala Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both JBG SMITH and Pharmala Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining JBG SMITH and Pharmala Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between JBG SMITH Properties and Pharmala Biotech Holdings, you can compare the effects of market volatilities on JBG SMITH and Pharmala Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in JBG SMITH with a short position of Pharmala Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of JBG SMITH and Pharmala Biotech.

Diversification Opportunities for JBG SMITH and Pharmala Biotech

0.35
  Correlation Coefficient

Weak diversification

The 3 months correlation between JBG and Pharmala is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding JBG SMITH Properties and Pharmala Biotech Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmala Biotech Holdings and JBG SMITH is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on JBG SMITH Properties are associated (or correlated) with Pharmala Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmala Biotech Holdings has no effect on the direction of JBG SMITH i.e., JBG SMITH and Pharmala Biotech go up and down completely randomly.

Pair Corralation between JBG SMITH and Pharmala Biotech

If you would invest  25.00  in Pharmala Biotech Holdings on September 17, 2024 and sell it today you would earn a total of  0.00  from holding Pharmala Biotech Holdings or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy1.56%
ValuesDaily Returns

JBG SMITH Properties  vs.  Pharmala Biotech Holdings

 Performance 
       Timeline  
JBG SMITH Properties 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days JBG SMITH Properties has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Pharmala Biotech Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pharmala Biotech Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Pharmala Biotech is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

JBG SMITH and Pharmala Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with JBG SMITH and Pharmala Biotech

The main advantage of trading using opposite JBG SMITH and Pharmala Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if JBG SMITH position performs unexpectedly, Pharmala Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmala Biotech will offset losses from the drop in Pharmala Biotech's long position.
The idea behind JBG SMITH Properties and Pharmala Biotech Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities